BILL GATES: THOUGHTS ON THE PANDEMIC
In 2015 Ezra Klein, founder of the Vox Network asked Bill Gates a question. What are you most afraid of? Gates reply is now well known. He was afraid of a flu-l...
GAZING OVER THE HORIZON AT CANCER TREATMENT
“The greatest curse is to be stuck in one’s own time; the greatest power is to see beyond its horizon.” Rachel Kadish, The Weight of Ink.
CAN THE COSMETIC OUTCOME BE IMPROVED IN THE POSTMASTECTOMY RECONSTRUCTED BREAST REQUIRING RADIATION?
With little fear of contradiction, one would assume that most patients requiring post-mastectomy radiation (PMRT) would undergo radiation prior to undergoing de...
Developing a Blood Test for Early Breast Cancer
Despite press releases that indicate otherwise, there is not yet a reliable blood test that improves our ability to detect early breast cancer. Even if there w...
FEATURED, Genetics, Opinion, Research
Somatic Cancer Mutations Accrue Over Years But Not All Become Cancer
Still a mystery why certain somatic mutations become cancerous while others don’t: It’s not merely a numbers game When researchers found that ”Somatic mutant ...
FEATURED, Opinion, Research, Genetic Testing, Neoadjuvant Therapy
Broad Implications for Personalized Recurrence Monitoring
A new approach to personalizing detection, monitoring, and delivering cancer treatment The blog below is authored by Peter Beitsch, MD based on a summary articl...
FEATURED, Imaging, Opinion, Research
Does MRI Offer Any Advantage Over Breast Tomography with Ultrasound when Screening for Breast Cancer?
Breast MRI is an accepted screening modality in genetically high-risk women and those whose calculated risk is high, as well as in women with dense breast tissu...
Should Breast Surgery Be Its Own Medical Specialty?
TME Breast Care Network doctor Peter Beitsch was one of the doctors discussing whether or not breast cancer surgery should be a specialty of general surgery. In...
Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit from Endocrine Therapy
Endocrine responsiveness of primary breast cancers with borderline ER (1%-9%) is unclear. Both ASCO and College 0f American Pathologists recommend that ER be de...
